University of Texas MD Anderson Cancer Center-ko ikertzaileekin lankidetzan egindako argitalpenak (2)

2014

  1. Targeting RPL39 and MLF2 reduces tumor initiation and metastasis in breast cancer by inhibiting nitric oxide synthase signaling

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 111, Núm. 24, pp. 8838-8843